Evidence map›Paper›PMID 39749207›Full record

ReviewFrontiers in pharmacology2024

Clade Ib: a new emerging threat in the Mpox outbreak.

Shriyansh Srivastava, Laxmi, Khyati Sharma, Sathvik Belagodu Sridhar, Sirajunisa Talath, Javedh Shareef, Rachana Mehta, Prakisini Satapathy, Ranjit Sah

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Observational
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shriyansh Srivastava *Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India.
Laxmi *Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India.
Khyati Sharma *Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India.
Sathvik Belagodu SridharRAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
Sirajunisa TalathRAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
Javedh ShareefRAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
Rachana MehtaDr. Lal PathLabs Nepal, Kathmandu, Nepal.
Prakisini SatapathyCenter for Global Health Research, Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India.
Ranjit SahDepartment of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monkeypox, a zoonotic virus in the

Indexed as

clade Ibemerging threatoutbreakspreventionsurveillancetransmission

Identifiers

PMID39749207
PMCPMC11693458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.